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ABSTRACT 
 Quorum sensing molecules have become a recent focus of study to learn if and how they 
can be used, both on their own and in conjecture with current antimicrobial methods, as a means 
of bacterial control. One such quorum sensing molecule is the sesquiterpene alcohol, Farnesol, 
which is synthesized and released by the fungus, Candida albicans. In most in-vivo cases, our 
laboratory has shown that Alcaligenes faecalis overtakes C. albicans, preventing its growth. 
However, as a way to counteract this inhibitory effect, Farnesol may be one way that Candida 
has found to fight back. In this study, we focused on the inhibitory properties of Farnesol for 
growth and motility of A. faecalis, as well as, the molecule’s ability to prevent Alcaligenes from 
creating biofilms and/or degrading them once they have already been established. Our 
experiments show evidence that Farnesol is able to inhibit both the growth and motility of A. 
faecalis, and determination of the specific concentrations of Farnesol needed to see the largest 
effects on A. faecalis biofilms. Our hope is that in future studies, we will be able to add varying 
concentrations of the Farnesol to known and widely used antibiotics in order to increase the 
effectiveness of antibiotics against bacterial strains, both in the Alcaligenes genus and in other 
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INTRODUCTION 
Antibiotics and Antibiotic Resistance: 
 Antibiotics have been in use since the 1940s when Penicillin was first released on 
the market, almost 12 years after Alexander Fleming first recognized its bacteria-fighting 
capabilities [1]. Since it was first released as a treatment for infections, there have been several 
advancements in the field of antibiotic treatments with numerous new medications being 
marketed for the public. The popularity and the use of these medications has continued to 
increase and with that comes the potential misuse of those medications. Bacteria naturally 
possess the ability to develop resistance in their typical environment; however, the misuse and 
overuse of antibiotics have expedited the resistance rate by accelerating the fast-adapting abilities 
of bacteria [2]. These adaptations have led to the need for more and more antibiotics to be 
researched and developed in order to keep up with the ever-growing resistance problems. 
However, producing antibiotics is not as economically advantageous as producing medications 
for chronic illnesses such as hypertension. Therefore, less funding has gone toward the research 
and production of new antibiotics by large pharmaceutical companies because they stand to 
make limited profit from the products [3]. This is true for antibiotics used against a wide 
spectrum of infections, but especially against Gram (-) bacteria. Gram (-) bacteria tend to possess 
faster resistance rates with no way to pinpoint exactly when the resistance will manifest itself, 
rather than many of the Gram (+) bacteria that are currently causing issues globally such as 
Methicillin Resistant Staphylococcus aureus. Many of the current Gram (-) bacteria already have 
strains that are resistant to most of the antibiotics currently available to patients. Since large 
pharmaceutical companies have severely decreased the amount of resources and time that they 
put forth to create new antibiotics, some smaller companies have tried to take over research and 
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production of new treatment methods. However, many new antibiotics do not get past the first 
two phases of research because the cost of the clinical trials in phase 3 is so expensive that many 
small companies and investors cannot afford to follow through the process [3].  
As published by the Centers for Disease Control in 2013, the world, as a whole, has 
entered into the “post-antibiotic era” [3]. The medical world is in desperate need of new methods 
for treating both simple and potentially deadly infections. Therefore, researchers have begun 
looking at how we can amplify the tools (medications) that are already available by also 
exploiting the ability of microorganisms to use secreted molecules to inhibit other microbes. 
Alcaligenes faecalis: 
 Alcaligenes faecalis is an aerobic, motile, Gram (-) bacilli bacterium found ubiquitously 
in the environment, specifically in water sources, soil and the normal gastrointestinal flora of 
humans. The A. faecalis species is the most common species in the genus to be isolated and 
cultured in a lab, but it is rarely cultured from clinical specimens [4] [5]. Due to its regular 
presence in the normal flora of human hosts, this bacterium rarely causes issues; however, A. 
faecalis is an opportunistic pathogen that can cause bacterial infections in immunocompromised 
hosts such as patients in hospitals or patients with chronic infections such as Cystic Fibrosis [4]. 
This pathogen has been associated with several types of infections including but not limited to 
skin and soft tissue infections, urinary tract infections, and pneumonia [5] [6] [7]. This bacterium 
is also commonly seen in nosocomial infections particularly after surgery/invasive procedures 
and due to interactions with fluids via nebulizer treatments and respirators [5]. Though it is still 
quite rare for A. faecalis to cause life-threatening septicemia, the occurrences of cases such as 
this has been on the rise. In July of 2019, at Square Hospitals Limited in Bangladesh, a patient 
was diagnosed with a bloodstream infection of A. faecalis that was resistant to all currently 
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available antibiotics, including the “reserve” antibiotics such as carbapenems and tigecycline [8]. 
This bacterium is quickly morphing into yet another pan-resistant bacterium that cannot be 
treated by the antibiotics we currently have available. Medicine needs a method for strengthening 
the antibiotics that are currently commercially available and creating new methods to fight back 
against such resistant infections. This study will begin to look at how Candida albicans may be 
able to fight back against Alcaligenes faecalis infections. 
Candida albicans:  
 Candida albicans is a fungus that is found commonly in healthy human microbial flora. 
Even so, this fungus is known as an opportunistic pathogen (much like A. faecalis) as it can 
cause illness in a human host, especially one that is immunocompromised due to illnesses, 
infections, or treatments for other diseases [9]. Fungi can have several similar effects on the 
human body as most bacteria. They can also interact with bacteria in the host body, resulting in 
either the amplification or hindrance of one or both microbes. Several interactions such as this 
have been studied regarding Candida’s interactions with Escherichia coli, Pseudomonas 
aeruginosa, Streptococcus, etc. [10]. The research discussed in this report will look at the 
interactions between C. albicans (particularly the quorum sensing molecule it produces, 
Farnesol) and A. faecalis.  
Quorum Sensing Molecules (Farnesol): 
 Quorum sensing is one of the many ways that bacteria communicate with one another. It 
was once thought to only occur in eukaryotic cells; however, it has been well documented in 
several bacterial genera [11]. If one bacterium turns on all of its virulence factors, it cannot cause 
severe damage to the human host and that one singular bacterium would easily be killed or 
expelled by the host’s immune system. However, if hundreds or thousands of bacteria are 
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present, they can release cell-population density signaling molecules that alert bacteria that 
enough individual cells are now present to cause damage. Once the number of bacterial cells 
inside the host reaches a certain threshold, the concentration of the cell density signaling 
molecules is also high enough to trigger expression of potentially harmful virulence factors. This 
process of quorum sensing communication is used by several different types of bacteria to carry 
out many biological functions including competence, motility, luminescence, etc. In the case of 
Farnesol produced by C. albicans, the molecule causes inhibitory functions against some 
competing bacteria [11]. 
 Farnesol is a sesquiterpene alcohol that is produced by the fungus C. albicans via the 
biosynthetic sterol pathway using farnesyl pyrophosphate (Fpp) as the starting material [12]. 
Farnesol controls several of the virulence factors that Candida can use against other competing 
fungi and some bacteria. These include, but are not limited to, biofilm formation and Candida’s 
ability to alternate between its three morphological states [13]. 
Objectives: 
 The research in this report examines the potential inhibitory functions of Farnesol 
production by C. albicans on the growth, motility, biofilm formation, and biofilm degradation of 
A. faecalis in vitro. Normally, when the two bacteria are grown together, A. faecalis overtakes C. 
albicans and inhibits its growth. Therefore, we looked at a possible countermeasure that Candida 
could use to fight back, and potentially inhibit, the growth of the Alcaligenes by using a molecule 
naturally produced by the fungus. 
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MATERIALS AND METHODS 
Microorganisms and Culture Conditions. C. albicans strain SC5314 was routinely cultured on 
Yeast Peptone Dextrose (YPD) agar and broth and grown at 37⁰C. A.faecalis strain  ATCC 8750 
and A. viscolactis was routinely cultured on Luria Bertani (LB) agar and broth and grown at 37⁰C 
or room temperature respectively. For co-cultures, Brain Heart Infusion (BHI) agar and broth 
were used. 
Inhibition of Growth. For disc diffusion tests, a lawn of A. faecalis was grown on an agar plate 
using a liquid culture grown 24 hours prior. Two filter disks: 1 containing 20µl of 4 molar 
Farnesol and 1 containing 20µl of C. albicans (also from a liquid broth grown 24 hours before) 
were placed 3 cm apart on the agar plate on top of the A. faecalis lawn. The plate was incubated 
at 37oC for 24 hours and monitored for zones of inhibition (ZOI). For line streak tests, on two 
separate BHI plates, a line of the liquid broth containing A. faecalis was drawn down the center 
using a sterile Q-tip for each plate. On the first plate, a line was also drawn immediately adjacent 
to the Alcaligenes line, but not touching, using Farnesol. On the second plate, the same technique 
was utilized with Phosphate Buffered Saline (PBS) acting as a control in place of the Farnesol. 
The two plates were incubated at 37oC for 24 hours. For spot tests, a liquid culture of A. faecalis 
grown overnight was used to make a lawn by spreading 100µl on an agar plate, allowed to dry, 
then 10µl of 4 molar Farnesol was spotted onto the lawn. The plate was then incubated at 37oC 
for 24 hours.  
Inhibition of Motility. Five tubes of liquid motility agar deeps were prepared. Two of the deeps 
contained 200µl of C. albicans from a liquid overnight culture along with the cooled molten 
motility agar. Two other deeps contained 25µl of Farnesol along with the normal motility agar 
media. The last deep contained only the normal motility agar. The broths were mixed, 
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respectively, chilled, and allowed to solidify and set for 24 hours. After the deeps were set, an 
overnight culture of A. faecalis liquid broth was used to aseptically stab into the center of 1 C. 
albicans deep, 1 Farnesol deep, and the control deep. The process was repeated by aseptically 
stabbing the 2 remaining tubes (1 C. albicans and 1 Farnesol) with a liquid overnight broth 
culture of A. viscolactis. All five tubes were incubated at 37oC (A. faecalis) or room temperature 
(A. viscolactis) for 24 hours.  
Liquid Co-Culture. 25 µl of fresh overnight cultures of A. faecalis, was added to two broth 
tubes and 60 µl Farnesol was added to one tube forming a co-culture. Both tubes were placed in 
the 37oC incubator with shaking (250rpm) for 24 hours. Each tube was serially diluted, plated 
onto agar plates containing either Kanamycin (50ug/ml) or Amphotericin B (25ug/ml), incubated 
for 24-hours at 37oC, and colony forming units (CFUs) were enumerated. Three independent 
trials were performed. 
Biofilm Growth. Prevention of Biofilm Attachment. 96 well plates were filled with broth only 
(blank control, Row A) or broth inoculated with an overnight culture of A. faecalis equilibrated 
to an OD600 of 0.01 (~1x106 cells/ml). Varying amounts of stock Farnesol (30µl of Farnesol 
and 1500µl broth) were added to Rows B-H of the 96 well plate (C – 15 microliters, D – 7.5 
microliters, E – 3.8 microliters, F – 1.8 microliters, G – 0.9 microliters, H – 0.5 microliters). The 
96 well plate was incubated at 37⁰C for 24 hours and divided into 3 sections for processing. The 
first section, columns 1 – 4 was processed for OD600 readings. The second section, columns 5 – 
8, was processed for MTT testing and OD 450 readings. Broth was removed from the wells, 
washed with 200µl of PBS, and PBS/MTT (200µl and 10µl respectively) was added to the wells. 
The well plate was then incubated at 37oC for 15 minutes, 100µl of Dimethylsulfoxide (DMSO) 
was added, and OD450 reading was taken. The third section, columns 9 – 12, was processed for 
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Crystal Violet (CV) staining and read at OD 600. Broth was removed from the wells, washed 
with 200 µl of PBS, 200µl of diluted 0.01% CV was added to all wells and incubated at room 
temperature for 5 minutes. Excess CV was washed off with 200µl of PBS, allowed to dry in the 
37oC for 15 minutes, 200µl of 33% Glacial Acetic Acid was added to lyse the cells open and the 
OD600 reading was taken. This procedure was performed in 3 trials to ensure accuracy. 
Inhibiting pre-formed biofilms. The process for this experimentation was performed similar to 
the process used to for biofilm attachment, however, the Farnesol was not added until after the 
A. faecalis biofilms had grown in the 37oC incubator for 24 hours. After those 24 hours, the same 
varying amounts of Farnesol were added and the well plate was again placed in the 37oC 
incubator for an additional 24 hours and processed for OD600, MTT, and CV staining. 
 
RESULTS AND DISCUSSION 
Inhibition of Growth: 
 Previously in our laboratory, we have shown that when A. faecalis is spotted onto C. 
albicans lawns, zones of inhibition (ZOI) are apparent after 24 hours. However, upon further 
incubation of those lawns, C. albicans can breach the ZOI of A. faecalis, thus indicating that C. 
albicans is initially inhibited, but may employ counter measures to fight A. faecalis. Though A. 
faecalis normally inhibits the growth of C. albicans and grows abundantly, even in the presence 
of the fungus, these experiments were completed to test Candida’s ability to fight back using 
Farnesol. In our disc diffusion test, the agar plate with the lawn of A. faecalis and the disks 
containing 4 molar Farnesol and C. albicans, respectfully, were analyzed for ZOI surrounding 
each disk. The disk soaked in C. albicans did not result in any inhibition of A. faecalis growth; 
however, there was a slight zone of inhibition surrounding the Farnesol disk (Figure 1).  
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Figure 1: Agar plates inoculated with a lawn of A. faecalis and the disks placed over the lawn containing C. 
albicans (labeled CA) or containing Farnesol (labeled F). There is an obvious zone of inhibition around the F disk. 
In the streak line test plates, the plate with the A. faecalis and PBS streaks resulted in 
normal overgrowth of the bacterial with no growth inhibition when challenged with PBS (Figure 
2). However, the plate containing the A. faecalis streak line and Farnesol streak line did result in 
inhibition of the bacterial growth. The bacteria grew along its streak and in the opposite 
direction, but it did not cross the barrier created by the Farnesol (Figure 3).  
  
Figure 2: Growth lines of A. faecalis next to the PBS streak. This served as the control for the experiment. 
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Figure 3: Line streak plates on agar of A. faecalis challenged with Farnesol. 
Similar results lending to Farnesol’s inhibitory properties was seen upon viewing the two 
agar plates that were seeded with the A. faecalis liquid culture and the A. faecalis + Farnesol 
liquid culture, respectfully. There was an obvious difference in the growth with the plate 
containing just the bacteria presenting with significantly more growth verses the growth of A. 
faecalis with diluted Farnesol added (Figure 4). 
 
Figure 4: Agar plate growth inhibition by Farnesol. On the left contains the inoculum of A. faecalis in LB. The LB 
plate on the right contains the inoculum of A. faecalis and Farnesol and has less growth than the plate on the left. 
 These tests demonstrate that A. faecalis could be inhibited by C. albicans’ quorum 
sensing molecule, Farnesol, and primarily examined growth. We then wanted to determine, 
visually, the ability of Candida to inhibit a more contact-dependent manner of motility. 
Inhibition of Motility 
 A. faecalis is usually an extremely motile bacteria and it is easily able to spread across its 
environment. Motility agar deeps were used to determine how motile the bacteria were in the 
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presence of C. albicans or its molecule, Farnesol. In the motility deep containing Farnesol, there 
is a clear red stab line from the A. faecalis; however, it does not spread significantly away from 
that immediate stab line (photo 1, Figure 5). The motility deep that contained the C. albicans 
showed significant growth at the top of the agar as well as minor growth near the beginning of 
the stab line before diminishing towards the middle/bottom of the tube (photo 2, Figure 5). The 
agar was also more turbid than the others. There is an obvious difference between the two tubes 
previously described and the control tube which contained only the motility agar. In this tube, 
there is a definite red stab line from the inoculation as well as notable spreading/radiation 
outwards (photo 3, Figure 5). We were also interested to see if inhibition by Candida and 
Farnesol was limited to A. faecalis or was shared by other species in the genus, particularly A. 
viscolactis. As for the deeps inoculated with A. viscolactis, there was no growth at any point in 
the tubes. However, there was not much growth in the original LB broth of A. viscolactis that had 
been prepared beforehand either. A viscolactis has a very slow generation time and specific 
temperature dependent growth characteristics so these could play a role in the differences seen 
between A. faecalis and A. viscolactis. 
 
Figure 5: Motility agar deeps. The Farnesol tube (far left) showed no growth emanating from the stab line. The C. 
albicans tube (middle) showed growth at the top of the motility agar deep. The control tube (far right) does show 
growth radiating from the stab line. 
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 From these results, it can be inferred that the Farnesol did inhibit the motility of the A. 
faecalis. Though the experimentation with the A. viscolactis did not present any results, working 
with other species in the Alcaligenes genus is an option for further research in the future. 
Liquid Co-Culture  
 We then wanted to turn our attention to finding out if Farnesol could inhibit the liquid 
growth of A. faecalis by enumerating the CFUs that A. faecalis can produce after exposure to 
Farnesol. The ability to do this would demonstrate that Farnesol does have the ability to restrict 
planktonic growth of the bacteria. For all three trials, the control, A. faecalis alone, and the 
experimental, A. faecalis with Farnesol, were grown in planktonic liquid culture for 24 hours at 
37⁰C, serially diluted, and plated. The plates from Trial 2 are pictured below in Figure 6. 
  
Figure 6: These pictures show the liquid cultures for trial 2 of this experiment. The picture on the left shows the 
control plates from the liquid cultures containing only A. faecalis. The order of the plates is top left (#1), bottom left 
(#3), bottom right (#5), top right (#7), and right center (#9). The picture on the right shows the plates containing 
growth from the liquid culture containing A. faecalis and Farnesol. The plate order is as follows: bottom left (#1), 
top left (#3), top right (#5), bottom right (#7), right middle (#9). 
 These results show that adding the Farnesol to the broth along with the A. faecalis before 
dilutions and plating, does indicate inhibition of A. faecalis growth, as opposed to the A. faecalis 
by itself (Figure 7). There is an average 11% decrease between the colony growth of the A. 
faecalis alone verses the A. faecalis with Farnesol growth. Further research could be done at a 
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later date to look at differing concentrations of Farnesol to see if increased amounts affect the 
CFU growth of A. faecalis differently. 
 
Figure 7: Log10 CFU counts for the liquid cultures performed using A. faecalis (AF) as a control and A. faecalis plus 
Farnesol (F). These are graphed above along with the standard deviations. There is an average 11% difference 
between the colony growth on the AF plates and the AF+F plates proving that the data obtained was statistically 
significant. 
Prevention of Biofilm Attachment 
Knowing that Farnesol inhibited planktonic growth of A. faecalis, we then wanted to 
examine any possible inhibitory effects on A. faecalis biofilm growth. Biofilms form in discreet, 
but fluid stages. The first stage of biofilm growth involves attachment of cells to a substrate. 
Thus, our first step was to test whether Farnesol could inhibit A. faecalis from initial attachment 
and subsequently inhibit biofilm growth by denying this primary step. In order to quantitate 
biofilm attachment, Farnesol was added to 96 well plates at the same time as inoculating the 
plate with A. faecalis. These biofilms were then processed in three different ways: OD595 
readings for biofilm turbidity (columns 1-4), MTT readings at OD450 (columns 5-8) for cell 
viability, and Crystal Violet readings at OD595 (columns 9-12) for biofilm mass. For the first 4 
columns, taking this normal OD595 reading shows the turbidity in the wells to see if the bacteria 
were growing and forming biofilms. However, this reading shows the cell density only, without 
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differentiating between living and dead cells. This also allowed us to determine which 
concentration of Farnesol would result in the least cell density. As seen in Figure 8, the 
concentration at which cell density was the lowest is 50µM, with cell density increasing as the 
graph spreads out in either direction. During the first analysis of these results, it was assumed 
that the higher concentration of Farnesol would result in a lower cell density; however, upon 
further research, 50µM is the concentration at which Farnesol would be seen at physiologically 
relevant levels in humans. It can be inferred that at the lower concentrations, there was not 
enough Farnesol molecules present to affect the A. faecalis. As for the higher concentrations, 
there is a possibility that the Farnesol and bacteria interacted in a different manner or the culture 
becomes over saturated, causing the cell density to be higher. 
 
Figure 8: This graph shows the average OD 595 readings (columns 1-4 in well plate) for the three biofilm 
attachment trials. 
The MTT test for columns 5-8, requires use of MTT. This is a yellow dye that is reduced 
by metabolically active cells to create a dark blue/black colored product called Formazan (15). 
This test differs from the original OD test because it allows us to look only at the living bacteria; 
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active. Only the cells that are attached in the biofilm are being tested because the other cells have 
been removed and washed away during the experimental process. Again, the ideal concentration 
of Farnesol was centered around the 50µM region with almost equal results stemming from the 
100µM and 25µM region. For this particular experiment, it is possible that the cells that are 
metabolically active would have a different reaction to the presence of Farnesol than the cells 
that are present and counted in the original OD595 reading but are dead. These results can be 
seen graphically in Figure 9. 
 
Graph 9: Average MTT - OD 450 readings (columns 5-8 in well plate) for the three biofilm attachment trials. 
As for the final 4 columns (columns 9-12), the Crystal Violet (CV) testing allows a visual 
representation of the biofilms and allows the overall mass of the A. faecalis biofilms to be 
analyzed. The amount of CV that is absorbed and released once the cells are lysed, tells if the 
ability to create biofilm mass is still present in the cells, even in the presence of Farnesol. As 
expressed in Figure 10, the ideal Farnesol concentration is closer to 25µM rather than the 50µM 
seen in the other experiments. As for the stark increase in cell mass at the 200µM region as 
opposed to the other concentrations, there was an outlier for Trial 2 of this test. In future testing, 
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this test could be replicated to rectify the outlier; however, with this being preliminary data, the 
outlier could not be eliminated from the analysis.  
 
Graph 10: Average Crystal Violet - OD 595 readings (columns 9-12 in well plate) for the three biofilm attachment 
trials. 
 Overall, the tests did show that the ideal concentration of Farnesol to work with and 
analyze in future studies, is around the 25µM – 100µM range with special attention to 50µM. 
These tests were used to determine what differences in concentrations of Farnesol would affect 
A. faecalis in these different biofilm quantitative methods. 
Biofilm Degradation 
 After demonstrating that Farnesol inhibited the attachment phase of A. faecalis biofilms, 
we then wanted to examine any possible inhibitory effects on mature A. faecalis biofilm growth. 
Mature biofilms can be up to 1000X more resistant to antibiotics and are very difficult to 
eradicate. Thus, our next step was to test whether Farnesol could inhibit A. faecalis pre-formed 
biofilms. In order to quantitate biofilm attachment, Farnesol was added to 96 well plates only 
after A. faecalis was allowed to form biofilms for 24 hours. These biofilms were then processed 











Control 200 uM 100 uM 50 uM 25 uM 12 uM 6 uM 3 uM
Attachment of Biofilm in Presence 
of Farnesol (CV - OD 595 Reading)
[AVERAGE]
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varying concentrations of Farnesol have on degrading A. faecalis biofilms that are already 
growing and have been doing so for 24 hours. We wanted to see if the same “ideal” 
concentrations remained constant between both experiments.  
For the original OD 595 readings, looking at turbidity and cell density, it is seen that the 
ideal concentration of Farnesol was 200µM with 25µM coming close behind. The 25µM was to 
be expected considering that it was one of the “ideal” concentrations listed in the attachment 
trials. However, the 200µM region was not expected. However, this may be due to the fact that a 
higher concentration of Farnesol was needed to break up the thicker growth of biofilms. The 
results from this experiment are pictured in Figure 11. The OD595 reading for the control which 
contained no Farnesol, was also lower than expected; however, according to the data collected, 
all three trials resulted in the same pattern (much lower control OD595 readings than with the 
readings for different Farnesol concentrations). At this point in time, the lab was in the process of 
ordering new Farnesol stocks, and it is a possibility that the Farnesol that was used for this set of 
experiments was already deactivated, causing the much lower numbers in the control OD595 
than the experimental values. Farnesol activity is very dependent on light and environmental 
conditions in which it is located. This anomaly could be studied more in future experiments, and 
the test itself could be run through more trials to ensure it was not researcher error. 
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Figure 11: Effects of varying concentrations of Farnesol on degradation of A. faecalis biofilms through OD595 
readings. 
 The results for the MTT test and OD450 readings for the degradation of existing biofilms 
looked much like the results seen for the normal OD595 readings. These results can be seen 
below in Figure 12. There is a significant drop in the number of metabolically active cells (in 
comparison to the other concentrations) at the 200µM Farnesol concentration. Again, this leads 
to the notion that a higher concentration works to degrade the cells because the biofilm has 
already been formed and needs more Farnesol to degrade it. However, the rest of the 
concentrations follow a similar pattern as the original OD595 readings as well, decreasing in the 
number of metabolically active cells until it reaches its lowest at 25µM and then slowing inching 
back up. 
23 | P a g e  
 
 
Figure 12: Effects of varying concentrations of Farnesol on degradation of A. faecalis biofilms through reduction of 
MTT and OD450 readings. 
 Lastly, we examined how varying concentrations of Farnesol would affect the overall cell 
mass of A. faecalis by staining with Crystal Violet and determining the OD595 readings. Though 
the 200µM concentration was not as low as expected after reviewing the averaged results of the 
previous two experiments, the results did follow a similar trend of having the 25µM 
concentration depleting the largest amount of cell mass. These results can be seen in Figure 13. 
 
Figure 13: Effects of varying concentrations of Farnesol on degradation of A. faecalis biofilms through Crystal 
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 The overall analysis of these results shows that although the 50µM concentration range of 
Farnesol was the “ideal” concentration when preventing A. faecalis from creating a biofilm, the 
“ideal” concentration for invoking the degradation of already formed A. faecalis biofilms is 
closer to the 200µM or 25µM regions. Further research would be able to look at these trials, 
replicate them, and attempt to test more concentrations. We can also look further at the 200µM 
concentration to see how it causes a reduction of A. faecalis in all trials, even though the 50µM – 
100µM concentrations had increased cell amounts. 
CONCLUSION 
 As a society, we are quickly approaching a time when the antibiotics we have come to 
rely on so heavily, are no longer going to be able to treat even the simplest of infections. Quorum 
sensing molecules such as Farnesol are one of the potentials that researchers have found that may 
offer a solution to this widespread problem. Our results from this preliminary research can 
continually be expanded in the future. Now that we have determined that there is evidence 
supporting Farnesol’s ability to inhibit growth, motility, and biofilm formation/degradation of 
Alcaligenes faecalis, there are several avenues that we can explore in future studies. These 
include, but are not limited to, adding the “ideal” Farnesol concentrations to currently used 
antibiotics to act as a synergistic form of treatment for infections while also testing Farnesol’s 
effects on other bacteria (both in the Alcaligenes genus and others). The hope is that this research 
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